Cours Isodiol International Inc Canadian Securities Exchange
Actions
CA46500L1013
Produits pharmaceutiques
CA 2018 | 19,14 M 26,18 M 17,23 M | CA 2019 | 22,25 M 30,44 M 20,03 M | Capitalisation | 49,96 M 68,35 M 44,98 M |
---|---|---|---|---|---|
Résultat net 2018 | -36 M -49,25 M -32,41 M | Résultat net 2019 | -126 M -172 M -113 M | VE / CA 2018 | 12,6 x |
Trésorerie nette 2018 | 15,55 M 21,27 M 14 M | Dette nette 2019 | 5,22 M 7,14 M 4,7 M | VE / CA 2019 | 2,48 x |
PER 2018 |
-4,94
x | PER 2019 |
-0,37
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 14/02/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 24/05/17 |
Director/Board Member | - | 30/08/18 | |
Director/Board Member | - | 21/11/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+26,93% | 5,55 Md | |
-33,55% | 3,52 Md | |
-3,74% | 3,03 Md | |
-26,09% | 2,59 Md | |
-10,93% | 2,28 Md | |
+41,50% | 1,88 Md | |
+41,84% | 1,46 Md | |
-12,94% | 1,43 Md | |
+47,62% | 1,42 Md |